BRAF V600E Mutation Positive Clinical Trials

5 clinical trials for BRAF V600E Mutation Positive across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Clinical-biological Prospective Cohort of Patients With BRAFV600E-mutated Metastatic Colorectal Cancer — RECRUITING · NA
• Encorafenib Plus Cetuximab in a Neoadjuvant Setting in Patients With BRAF Mutation Localised Colon or Upper Rectum Cancer — RECRUITING · PHASE2
• Clinical Study of Neoadjuvant Targeted Therapy for Ameloblastoma — RECRUITING · PHASE2
• A Retrospective Non Interventional Study on First Line Treatment for Patients With BRAFV600E Mutant Metastatic Colorectal Cancer (mCRC) — COMPLETED
• Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers — COMPLETED · PHASE1

Refine this search